3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Sarcoma
16
Central Nervous System Neoplasms
10
Gliosarcoma
9
Glioblastoma
9
Osteosarcoma
8
Astrocytoma
6
Sarcoma, Ewing
5
Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Lung Neoplasms
3
Breast Neoplasms
3
Brain Neoplasms
3
Waldenstrom Macroglobulinemia
2
Stomach Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Extranodal NK-T-Cell
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia
2
Glioma
2
Esophageal Neoplasms
2
Dendritic Cell Sarcoma, Interdigitating
2
Colorectal Neoplasms
2
Interventions
Docetaxel
3
trastuzumab deruxtecan
2
entrectinib
2
Magnetic Resonance Spectroscopy
2
Fluorodeoxyglucose F18
2
Erlotinib Hydrochloride
2
Biopsy
2
pembrolizumab
1
larotrectinib
1
entinostat
1
ceralasertib
1
alectinib
1
Thalidomide
1
Taxes
1
Specimen Handling
1
Ritonavir
1
Radiotherapy
1
Quality of Life
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Irinotecan
1
Indinavir
1
Immunotherapy
1
Immunohistochemistry
1
Gene Expression Profiling
1
Gemcitabine
1
Fluorescent Antibody Technique
1
Flow Cytometry
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Drug Therapy
×
Sarcoma
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled